Literature DB >> 2874759

Independent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstruction.

D S Postma, K de Vries, G H Koëter, H J Sluiter.   

Abstract

We evaluated factors that might influence the course of lung function after 2 to 21 yr of follow-up in 81 nonallergic patients with chronic air-flow obstruction (CAO) and considerable lung function impairment (initial forced expiratory volume in one second as a percentage of inspiratory slow vital capacity (FEV1 % VC) ranging from 40 to 55% and increasing less than 15% after the administration of the anticholinergic bronchodilator thiazinamium). A more favorable rate of change in FEV1 was associated with less pack-years of smoking, less nonspecific hyperreactivity, and a higher degree of reversibility of air-flow obstruction, when expressed as the increase in FEV1 as a percentage of the predicted minus prebronchodilator FEV1 value. Nonspecific hyperreactivity and reversibility of air-flow obstruction appeared to influence the decline in FEV1 independently of baseline value of FEV1, both in smokers and ex-smokers. The hypothesis is put forward that regular bronchodilating therapy may be able to prevent deterioration of lung function. However, the possibility that interval therapy may ultimately produce the same results cannot be excluded. It seems to be important to stop smoking, both for the sake of its negative influence on the course of FEV1 and for the fact that a beneficial influence of bronchodilating therapy may become even more apparent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874759     DOI: 10.1164/arrd.1986.134.2.276

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  33 in total

Review 1.  Airway hyperresponsiveness and COPD mortality.

Authors:  J Vestbo; E F Hansen
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Getting some breathing room--persuading patients to stop smoking.

Authors:  F E Speizer
Journal:  West J Med       Date:  1992-11

Review 3.  Determinants and regulating processes in bronchial hyperreactivity.

Authors:  H J Neijens
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS.

Authors: 
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

Review 5.  Decline of FEV1 by age and smoking status: facts, figures, and fallacies.

Authors:  H A Kerstjens; B Rijcken; J P Schouten; D S Postma
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

6.  [Recommendations for implementing bronchial provocation tests with pharmacologic substances. German Society of Pneumology--Scientific "Bronchial Provocation Tests" Study Group].

Authors:  G Klein
Journal:  Med Klin (Munich)       Date:  1997-08-15

7.  Proceedings of the British Thoracic Society. 12-14 July 1989, University of Southampton. Abstracts.

Authors: 
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

Review 8.  Clinical expression of airway hyperreactivity in adults.

Authors:  D S Postma; G H Koëter; K de Vries
Journal:  Clin Rev Allergy       Date:  1989

9.  Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.

Authors:  J W de Jong; G H Koëter; T W van der Mark; D S Postma
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

10.  Inhaled corticosteroids in COPD: awaiting controlled trials.

Authors:  J A Wedzicha
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.